The expanding CML treatment landscape: an introspective commentary
Blood Cancer J
.
2023 Sep 13;13(1):145.
doi: 10.1038/s41408-023-00918-3.
Author
Jeffrey H Lipton
1
Affiliation
1
Leukemia Group, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. jeff.lipton@uhn.ca.
PMID:
37699881
PMCID:
PMC10497561
DOI:
10.1038/s41408-023-00918-3
No abstract available
Publication types
Editorial